ZENSARTECH

What Zensar Technologies promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q1 FY27

what the last two calls moved 13 tracked 5 delivered 2 missed 6 open
  • EBITDA Margin delivered said Q1 FY26 Promised: Remain in the mid-teens margin range. Q1 FY27: Achieved. Q1 EBITDA margin was 14.6% (down 150 bps QoQ from 16.1%), which remains within the mid-teens range. Management guided for similar margins in Q2/Q3 due to investments.
  • Manufacturing & Consumer Services Revenue Growth went quiet said Q1 FY26 Promised: Predicting growth in this vertical in Q2. Q1 FY27: Target period (Q2 FY26) has long passed. The promise remains unaddressed. In Q1 FY27, the vertical declined 2.3% sequentially.
  • Healthcare/Life Sciences FY27 Revenue Growth at risk said Q4 FY26 Promised: Hoping that we can remain at least flat in Healthcare, Life Sciences for FY27. Q1 FY27: At risk. The HLS vertical declined 3.8% sequentially in Q1. While management expects growth in subsequent quarters, this initial decline puts the FY27 target of 'at least flat' performance at risk.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 13 tracked commitments for Zensar Technologies — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens